Most Popular

ImmunityBio: Anktiva Explained and What Comes Next

ImmunityBio IBRX is building a portfolio of immunotherapies designed to activate both innate and adaptive immunity in cancer and infectious diseases. Its Cancer BioShield platform centers on Anktiva (nogapendekin alfa inbakicept), an interleukin-15 receptor superagonist antibody-cytokine fusion protein built to stimulate natural killer cells, cytotoxic …

Read more

CrowdStrike Holdings Takes Over #72 Spot From Netflix

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, CrowdStrike Holdings Inc (Symbol: CRWD) has taken over the #72 spot from Netflix Inc (Symbol: NFLX), according to ETF Channel. Below is a chart of CrowdStrike Holdings …

Read more

The Case for and Against Buying Ford Stock Right Now

Key Points Ford’s price-to-earnings ratio of 11.3 supports a hefty dividend yield of more than 4%. As a mass-market carmaker, this company is characterized by low growth and weak profits. The automotive stock’s long-term shareholder track record doesn’t provide a reason to be optimistic. 10 …

Read more

Crypto Market Update: FalconX Files Confidential US IPO

Here’s a quick recap of the crypto landscape for Friday (May 29) as of 12 noon UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrencymarket news Bitcoin (BTC) was priced at US$73,359.90, trading flat over the past …

Read more

Alibaba Stock May Be One of the Safest Ways to Play the AI Boom Right Now

Key Points The Chinese company’s AI growth is already visible. It has a built-in capital supply with its e-commerce business. That creates a better risk-reward profile than many high-profile AI stocks. 10 stocks we like better than Alibaba Group › Artificial intelligence (AI) has become …

Read more

Tesla Stock Gets Wall Street Upgrade on Robotaxi Potential

Key Points Tesla (NASDAQ: TSLA) is a stock that divides Wall Street analysts, with Piper Sandler, Canaccord Genuity, and Wedbush in the bullish camp currently, with respective price targets of $500, $450, and $600; while UBS and Barclays take a more skeptical view with their …

Read more

The Inflation Numbers Were a Disaster. Here’s the Silver Lining…

Investors may be missing the much bigger story unfolding beneath the headlines. Listen to the audio version of this article (generated by AI). When this week’s inflation numbers dropped, I used two words to describe them in a Special Market Podcast I sent to my …

Read more

InterGroup Climbs 45% Year to Date: Should You Buy the Stock?

The InterGroup Corporation INTG shares have gained 45% year to date against the industry’s 6.3% decline. The company has outperformed other industry players, including New World Development Company Limited NDVLY and Forestar Group Inc. FOR. Shares of NDVLY and FOR have rallied 15.1% and 11.3%, …

Read more

Wall Street Expected a Slowdown in Q2. Corporate America Had Other Plans.

Key Points The big rally since late March has more than undone the market weakness earlier this year. This bullishness, however, isn’t evenly distributed. Neither is the underlying growth driving it. Investors will want to exercise some caution from here for a handful of reasons. …

Read more

Surprise! This AI Giant That’s Climbed 1,200% Over 5 Years is Now the Second Cheapest of the Magnificent Seven

Key Points Artificial intelligence (AI) stocks have soared over the past few years amid excitement about the promise of this new technology. The idea is that AI tools and services may help companies save time and money and become more innovative — and the result …

Read more